| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1681 |
| Trial ID | NCT02992834 |
| Disease | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase4 |
| Recruitment status | Unknown |
| Title | Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma |
| Year | 2016 |
| Country | China |
| Company sponsor | The First People's Hospital of Changzhou |
| Other ID(s) | CAAA |
| Cohort1: IL-2 | |||||||||||
|
|||||||||||
| Cohort2: IL-7/IL-15 | |||||||||||
|
|||||||||||